The non-viral in vivo-jetPEI™ reagent is suitable for the transfection of DNA, siRNA and oligonucleotides in vivo.

This linear polyethylenimine reagent is used for local and systemic injections in a wide range of animal models and is currently used in phase I human clinical trials as a delivery vector for cancer gene therapy.